Lurasidone Hydrochloride Tablet, Film Coated
Product Images NDC 43598-355

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lurasidone Hydrochloride (NDC 43598-355). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddys Laboratories Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (290c7038 Fd8c 4250 8569 99793e8864ea 01)

Chemical structure of Lurasidone Hydrochloride showing its molecular framework including multiple rings and bonds, consistent with the active ingredient lurasidone hydrochloride used in the medication.*

FDA Label Image

Image (290c7038 Fd8c 4250 8569 99793e8864ea 02)

A horizontal dot plot chart titled 'Impact of other drugs on Lurasidone Pharmacokinetics (PK)'. It displays fold change and 90% confidence intervals for various interacting drugs (Ketoconazole, Diltiazem, Rifampin, Lithium) affecting Lurasidone plasma concentration parameters Cmax and AUC. The x-axis shows change relative to Lurasidone alone, ranging approximately from -4 to 4 fold change, with points indicating increases or decreases in pharmacokinetic metrics.*

FDA Label Image

Image (290c7038 Fd8c 4250 8569 99793e8864ea 03)

A horizontal dot plot showing fold change and 90% confidence intervals for pharmacokinetic parameters of various interacting drugs with Lurasidone Hydrochloride. The graph compares change relative to each interactive drug alone, listing drugs such as Digoxin, Midazolam, Ethinyl Estradiol, Noregestromin, and Lithium with respective pharmacokinetic measures like Cmax, AUC, and Ctrough.*

FDA Label Image

Figure 3: Impact Of Other Patient Factors On Lurasidone Hydrochloride Pharmacokinetics (290c7038 Fd8c 4250 8569 99793e8864ea 04)

A chart showing fold change and 90% confidence intervals for pharmacokinetic parameters Cmax and AUC related to renal impairment, hepatic impairment, and population descriptions including gender and race, with change relative to a reference indicated on the x-axis.*

FDA Label Image

Container120mg (Container120mg)

Label for Lurasidone Hydrochloride Tablets 120 mg oral film-coated tablets by Dr. Reddy's Laboratories Inc. The label displays the product name and strength in bold, package count of 30 tablets, NDC 43598-355-30, and storage instructions. It includes a barcode and a designated area for printing batch, expiration, and serialization details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.